Unterehmen auf Watchlist setzen
Aequus Pharmaceuticals Inc.
ISIN: CA0076361033
WKN: A2ASE5
Curious about what AI knows about Aequus Pharmaceuticals Inc.? Just one click more
More AI Integrations
Über
Unternehmensprofil
Tipp: Investor-Alerts aktivieren
Lassen Sie sich bei neuen Publikationen informieren
Tipp: AI-Factsheet

Corporate News meets AI! 
Analyse der Inhalte und Zusammenfassung

Aequus Pharmaceuticals Inc. · ISIN: CA0076361033 · PR Newswire (ID: 20250425C6605)
25 April 2025 07:11PM

Canadian Investment Regulatory Organization Trading Halt - AQS


VANCOUVER, BC, April 25, 2025 /CNW/ - The following issues have been halted by CIRO

Company: Aequus Pharmaceuticals Inc.

TSX-Venture Symbol: AQS

All Issues: Yes

Reason: Failure to Maintain Exchange Requirements

Halt Time (ET): 12:58 pm

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Canadian Investment Regulatory Organization (CIRO) – Halts/Resumptions

Visuelle Wertentwicklung / Kursverlauf · Aequus Pharmaceuticals Inc.
Smarte Analyse- und Recherchewerkzeuge finden Sie hier.
MIC: XTSX
Power-Shortcuts

Aequus Pharmaceuticals Inc.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2025
PR Newswire
Kontakt:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942